Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Small Cell Lung Carcinoma 10Ovarian Neoplasms 9Carcinoma, Ovarian Epithelial 8Neuroblastoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia 5Fallopian Tube Neoplasms 5Uterine Cervical Neoplasms 4Myelodysplastic Syndromes 4Lung Neoplasms 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Acute 4Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Polycythemia Vera 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Ganglioneuroblastoma 3Carcinoma, Non-Small-Cell Lung 3Anemia, Refractory, with Excess of Blasts 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Carcinoma, Neuroendocrine 2

Interventions

Vincristine 3Radiotherapy 3Ifosfamide 3Etoposide 3Doxorubicin 3Dactinomycin 3Cyclophosphamide 3Carboplatin 3Epirubicin 2romidepsin 1cixutumumab 1Vinorelbine 1Topotecan 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1NHS-IL12 immunocytokine 1Molecular Diagnostic Techniques 1Microarray Analysis 1HhAntag691 1Filgrastim 1Chemotherapy, Adjuvant 1Brachytherapy 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Malignant mesenchymal tumor × Topotecan × Clear all
NCT00379457 2013-08-12

Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
600 enrolled
Sarcoma

Malignant mesenchymal tumor, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡